Clinical Trials Logo

Clinical Trial Summary

A retrospective cohort of solid organ transplant (SOT) and hematopoietic stem cell transplant (HSCT) recipients will be assembled to determine the incidence of respiratory viral infections diagnosed during an inpatient admission in the first year post-transplant. A sub-cohort of patients that develop a respiratory viral infection within one year of transplantation will be leveraged to investigate factors associated with mortality in the three months after respiratory viral infection.


Clinical Trial Description

The purpose of the study is to 1) Determine the incidence of respiratory viral infections diagnosed during the first year post SOT and HSCT; 2a) Determine the all-cause mortality within 3 months of a respiratory viral infection diagnosed during an inpatient admission in the first year post SOT and HSCT; 2b) Determine the proportion of deaths within 3 months of a respiratory viral infection diagnosed during an inpatient admission deemed to be directly attributable to that infection; and 3) To identify factors known at time of onset of the inpatient respiratory viral infection that are associated with all-cause mortality. The study cohort will consist of any SOT or HSCT recipient ≤18 years of age that received their transplant between January 1st, 2010 and June 30th, 2013. Th cohort will determine the incidence of respiratory viral infections diagnosed during an inpatient admission in the first year post-transplant. A sub-cohort of patients that develop a respiratory viral infection within one year of transplantation will be leveraged to investigate factors associated with mortality in the 3 months after respiratory viral infection. Baseline and demographic characteristics will be summarized by standard descriptive summaries. Categorical variables will be summarized by frequencies while continuous variables will be summarized using mean, standard deviation and/or median, twenty-fifth and seventy-fifth percentiles, minimum, and maximum. This is a minimal risk study using data that will be collected retrospectively from medical charts. The only potential risk would be loss of confidentiality. ;


Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT02260596
Study type Observational
Source Duke University
Contact
Status Completed
Phase N/A
Start date September 2014
Completion date August 2015

See also
  Status Clinical Trial Phase
Terminated NCT04898023 - Zinc and Green Tea Extract for Community Respiratory Viral Infections Phase 2
Withdrawn NCT04842331 - PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT) Phase 2/Phase 3
Not yet recruiting NCT06099873 - A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Trial of ZX-7101A Tablets to Evaluate the Efficacy and Safety in the Treatment of Uncomplicated Influenza in Adolescents Phase 3
Completed NCT04898140 - The Evaluation of Cellular and Humoral Immunity to COVID-19 in Moscow Residents
Completed NCT04611061 - Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers
Not yet recruiting NCT05618483 - Xylitol Based Nasal Spray for COVID-19 Treatment N/A
Recruiting NCT06149494 - RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection Phase 2
Terminated NCT04141917 - Test-and-treat for Influenza in Homeless Shelters Phase 4
Recruiting NCT06017310 - Respiferon Project
Enrolling by invitation NCT06188988 - Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis
Completed NCT04141930 - Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle Phase 4
Completed NCT05846360 - The Technical and Operational Performance of the QuidelOrtho Savanna RVP4 Analyzer
Completed NCT04532411 - COVID-19 Testing Sample Acquisition Throughput and Efficiency
Active, not recruiting NCT04258059 - Wells and Enteric Disease Transmission Trial (WET - Trial) N/A
Active, not recruiting NCT04482673 - Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection Phase 4
Not yet recruiting NCT05946538 - Clinical Evaluation of SARS-COV-2 (COVID-19), Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics N/A
Recruiting NCT05092607 - Evaluation of the Detection Performance of the N Antigenemia of SARS-CoV-2 in the General Population for the Diagnosis and Screening of COVID-19 N/A
Recruiting NCT05913700 - Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
Recruiting NCT04826991 - Wells and Enteric Disease Transmission N/A
Terminated NCT04664075 - Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)